Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-14 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-14 inhibits the replication of influenza virus. Cap-dependent endonuclease-IN-14 has the potential for the research of viral infections caused by influenza viruses (extracted from patent CN113620948A, compound 1-c)[1].
Web ID
– HY-143768
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C30H23FN2O6S
References
– [1]Zhuqiang Lin, et al. cap-dependent endonuclease inhibitor. Patent CN113620948A.
CAS Number
– 2740486-73-9
Molecular Weight
– 558.58
SMILES
– O=C(OCOC1=C(C(C2(CC2)CN3C4C5=C(C6=C(C7=CC(F)=CC=C74)C=CS6)C=CC=C5)=O)N3C=CC1=O)OC
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
